First Time Loading...
V

Voxel SA
WSE:VOX

Watchlist Manager
Voxel SA
WSE:VOX
Watchlist
Price: 93.2 PLN 0.22% Market Closed
Updated: May 13, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Voxel SA

Revenue
424.2m PLN
Cost of Revenue
-283.8m PLN
Gross Profit
140.3m PLN
Operating Expenses
-22.9m PLN
Operating Income
117.5m PLN
Other Expenses
-43.3m PLN
Net Income
74.2m PLN

Margins Comparison
Voxel SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
PL
Voxel SA
WSE:VOX
978.8m PLN
33%
28%
17%
US
Cigna Group
XMUN:CGN
92.4B EUR
12%
5%
2%
US
Cigna Corp
NYSE:CI
99B USD
12%
5%
2%
US
CVS Health Corp
NYSE:CVS
69.9B USD
15%
4%
2%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.5B USD
28%
9%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR
23%
5%
-3%
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.9B EUR
25%
7%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.4B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12.1B USD
32%
14%
7%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country PL
Market Cap 978.8m PLN
Gross Margin
33%
Operating Margin
28%
Net Margin
17%
Country US
Market Cap 92.4B EUR
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 99B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 69.9B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 17.5B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country DE
Market Cap 16.1B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 15.4B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11.9B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 11.4B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12.1B USD
Gross Margin
32%
Operating Margin
14%
Net Margin
7%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Voxel SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
PL
Voxel SA
WSE:VOX
978.8m PLN
28%
15%
30%
23%
US
Cigna Group
XMUN:CGN
92.4B EUR
8%
2%
9%
7%
US
Cigna Corp
NYSE:CI
99B USD
8%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
69.9B USD
10%
3%
8%
6%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.5B USD
5%
2%
7%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR
-3%
-1%
2%
1%
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.9B EUR
4%
1%
4%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.4B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
12.1B USD
93%
5%
12%
9%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country PL
Market Cap 978.8m PLN
ROE
28%
ROA
15%
ROCE
30%
ROIC
23%
Country US
Market Cap 92.4B EUR
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 99B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 69.9B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country US
Market Cap 17.5B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 16.1B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 15.4B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.9B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country DE
Market Cap 11.4B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 12.1B USD
ROE
93%
ROA
5%
ROCE
12%
ROIC
9%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More